Cromwell Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13M Buy
2,613
+275
+12% +$281K 1.41% 13
2026
Q1
$2.15M Hold
2,338
1.21% 12
2025
Q4
$2.51M Hold
2,338
1.37% 12
2025
Q3
$1.78M Hold
2,338
0.95% 14
2025
Q2
$1.82M Hold
2,338
1.11% 13
2025
Q1
$1.93M Hold
2,338
1.24% 13
2024
Q4
$1.8M Hold
2,338
1.04% 16
2024
Q3
$2.07M Hold
2,338
1.33% 10
2024
Q2
$2.12M Buy
+2,338
New +$1.87M 1.27% 11

Other funds holding LLY

Cromwell Holdings's LLY Position: Q2 2026 in Review

Cromwell Holdings increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $281K and bringing the position to 2,613 shares worth $3.13M. The position accounts for 1.41% of the portfolio, ranked #13.

Cromwell Holdings first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cromwell Holdings held 2,613 shares of Eli Lilly worth $3.13M as of Q2 2026.
  • Cromwell Holdings bought 275 Eli Lilly shares in Q2 2026, an estimated $281K.
  • Eli Lilly made up 1.41% of Cromwell Holdings's portfolio in Q2 2026, its #13 holding.
  • Cromwell Holdings first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.